FORM N-PX PROXY VOTING RECORD
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | COLUMN 9 | COLUMN 10 | COLUMN 11 | COLUMN 12 | COLUMN 13 | COLUMN 14 | COLUMN 15 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAME OF ISSUER |
CUSIP | ISIN | FIGI | MEETING DATE | VOTE DESCRIPTION | VOTE CATEGORY | DESCRIPTION OF OTHER CATEGORY | VOTE SOURCE | SHARES VOTED | SHARES ON LOAN | DETAILS OF VOTE | MANAGER NUMBER | SERIES ID | OTHER INFO | ||
| HOW VOTED | SHARES VOTED | FOR OR AGAINST MANAGEMENT | ||||||||||||||
| ALECTOR INC | 014442107 | US0144421072 | BBG00NGHXD36 | 06/12/2024 | Advisory vote on executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | - | 0 | 0 | - | - | ||||
| 23ANDME HOLDING CO | 90138Q108 | US90138Q1085 | BBG00XV5CYH5 | 09/06/2023 | A non-binding, advisory vote on the Fiscal 2023 compensation of the Company's named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | - | 0 | 0 | - | - | ||||
| PMV PHARMACEUTICALS INC | 69353Y103 | US69353Y1038 | BBG007NM47G3 | 06/06/2024 | Approval, on a non-binding advisory basis, the compensation of our named executive officers | SECTION 14A SAY-ON-PAY VOTES |
- | - | 0 | 0 | - | - | ||||
| QUALIGEN THERAPEUTICS INC | 74754R202 | US74754R2022 | BBG008D03RS4 | 07/13/2023 | To approve on a non-binding, advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 17482.4 | 0 | FOR |
17482.4 |
FOR |
- | - | |
[Repeat as Necessary]